Literature DB >> 33301864

An integrated computational methodology with data-driven machine learning, molecular modeling and PBPK modeling to accelerate solid dispersion formulation design.

Hanlu Gao1, Wei Wang1, Jie Dong1, Zhuyifan Ye1, Defang Ouyang2.   

Abstract

Drugs in solid dispersion (SD) take advantage of fast and extended dissolution, thus attains a higher bioavailability than the crystal form. However, current development of SD relies on a random large-scale formulation screening method with low efficiency. Current research aims to integrate various computational tools, including machine learning (ML), molecular dynamic (MD) simulation and physiologically based pharmacokinetic (PBPK) modeling, to accelerate the development of SD formulations. Firstly, based on a dataset consisting of 674 dissolution profiles of SD, the random forest algorithm was used to construct a classification model to distinguish two types of dissolution profiles: "spring-and-parachute" and "maintain supersaturation", and a regression model to predict the time-dependent dissolution profiles. Both of the two prediction models showed good prediction performance. Moreover, feature importance was performed to help understand the key information that contributes to the model. After that, the vemurafenib (VEM) SD formulation in previous report was used as an example to validate the models. MD simulation was used to investigate the dissolution behavior of two SD formulations with two polymers (HPMCAS and Eudragit) at the molecular level. The results showed that the HPMCAS-based formulation resulted in faster dissolution than the Eudragit formulation, which agreed with the reported experimental results. Finally, a PBPK model was constructed to accurately predict the human pharmacokinetic profile of the VEM-HPMCAS SD formulation. In conclusion, combined computational tools have been developed to in silico predict formulation composition, in vitro release and in vivo absorption behavior of SD formulations. The integrated computational methodology will significantly facilitate pharmaceutical formulation development than the traditional trial-and-error approach in the laboratory.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dissolution profile; Machine learning; Pharmacokinetic modeling; Solid dispersion; molecular dynamics (MD) simulations

Year:  2020        PMID: 33301864     DOI: 10.1016/j.ejpb.2020.12.001

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  5 in total

1.  Enhancing Atorvastatin In Vivo Oral Bioavailability in the Presence of Inflammatory Bowel Disease and Irritable Bowel Syndrome Using Supercritical Fluid Technology Guided by wbPBPK Modeling in Rat and Human.

Authors:  Mo'tasem M Alsmadi; Nour M Al-Daoud; Rana M Obaidat; Niazy A Abu-Farsakh
Journal:  AAPS PharmSciTech       Date:  2022-05-18       Impact factor: 3.246

2.  Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm.

Authors:  Wei Wang; Shuo Feng; Zhuyifan Ye; Hanlu Gao; Jinzhong Lin; Defang Ouyang
Journal:  Acta Pharm Sin B       Date:  2021-12-02       Impact factor: 14.903

3.  Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches.

Authors:  Zhoumeng Lin; Wei-Chun Chou; Yi-Hsien Cheng; Chunla He; Nancy A Monteiro-Riviere; Jim E Riviere
Journal:  Int J Nanomedicine       Date:  2022-03-24

Review 4.  Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms.

Authors:  Timothy R Lex; Jason D Rodriguez; Lei Zhang; Wenlei Jiang; Zongming Gao
Journal:  AAPS J       Date:  2022-03-11       Impact factor: 4.009

5.  Integrated in silico formulation design of self-emulsifying drug delivery systems.

Authors:  Haoshi Gao; Haoyue Jia; Jie Dong; Xinggang Yang; Haifeng Li; Defang Ouyang
Journal:  Acta Pharm Sin B       Date:  2021-05-05       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.